These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36732869)
1. M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients. Li DX; Feng DC; Wang XM; Wu RC; Zhu WZ; Chen K; Han P Eur J Med Res; 2023 Feb; 28(1):55. PubMed ID: 36732869 [TBL] [Abstract][Full Text] [Related]
2. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer. Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
4. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma. Regmi P; He ZQ; Lia T; Paudyal A; Li FY Front Genet; 2022; 13():918983. PubMed ID: 35734429 [No Abstract] [Full Text] [Related]
5. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer. Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712 [TBL] [Abstract][Full Text] [Related]
6. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma. Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M Front Oncol; 2022; 12():1055605. PubMed ID: 36761423 [TBL] [Abstract][Full Text] [Related]
7. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
8. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer. Li T; Chen Z; Wang Z; Lu J; Chen D Front Immunol; 2023; 14():1260195. PubMed ID: 37868988 [TBL] [Abstract][Full Text] [Related]
9. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer. Xie S; He J; Feng B; Rao D; Wang S; He Y Heliyon; 2023 May; 9(5):e15897. PubMed ID: 37215925 [TBL] [Abstract][Full Text] [Related]
10. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer. Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X Front Immunol; 2022; 13():984149. PubMed ID: 36300121 [TBL] [Abstract][Full Text] [Related]
11. Identification of endothelial-related molecular subtypes for bladder cancer patients. Li DX; Feng DC; Shi X; Wu RC; Chen K; Han P Front Oncol; 2023; 13():1101055. PubMed ID: 37025597 [TBL] [Abstract][Full Text] [Related]
12. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma. Zhu Y; Zhao Z; Thandar M; Cheng J; Chi P; Huang S BMC Gastroenterol; 2023 Jan; 23(1):22. PubMed ID: 36681801 [TBL] [Abstract][Full Text] [Related]
13. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X Front Genet; 2022; 13():929035. PubMed ID: 36081998 [No Abstract] [Full Text] [Related]
15. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers. He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ Front Genet; 2022; 13():998147. PubMed ID: 36226166 [No Abstract] [Full Text] [Related]
16. A signature of five 7-methylguanosine-related genes is a prognostic marker for lung squamous cell carcinoma. Liu W; Wang Y; Ulivi P; Tavolari S; Rizvi SAA; Capobianco E; Navarro A; Zhang Y J Thorac Dis; 2023 Nov; 15(11):6265-6278. PubMed ID: 38090319 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W; Liu C; Wang M; Jiang W; Wang C; Zhang S Front Genet; 2022; 13():906496. PubMed ID: 35938009 [TBL] [Abstract][Full Text] [Related]
18. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer. Ma M; Li J; Zeng Z; Zheng Z; Kang W Front Immunol; 2023; 14():1096488. PubMed ID: 36936957 [TBL] [Abstract][Full Text] [Related]
20. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. Li K; Wang W Front Genet; 2022; 13():981392. PubMed ID: 36313441 [No Abstract] [Full Text] [Related] [Next] [New Search]